Skip to main content

Design Therapeutics Inc

For the period ended Dec 31, 2024. Filed Mar 10, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 10, 2025

DSGN$10.65-1.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Power of Attorney (see signature page hereto)

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

Design Therapeutics, Inc.
Date: March 10, 2025By:/s/ Pratik Shah, Ph.D.
Pratik Shah, Ph.D.
President, Chief Executive Officer and Chairperson

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Pratik Shah, Ph.D., as his or her true and lawful attorney-in-fact and agents, with the full power of substitution, for him or her and in his or her name, place or stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

NameTitleDate
/s/ Pratik Shah, Ph.D.President, Chief Executive Officer and Chairperson(Principal Executive and Financial Officer)March 10, 2025
Pratik Shah, Ph.D.
/s/ Julie BurgessChief Accounting Officer (Principal Accounting Officer)March 10, 2025
Julie Burgess
/s/ Simeon George, M.D.DirectorMarch 10, 2025
Simeon George, M.D.
/s/ Rodney Lappe, Ph.D.DirectorMarch 10, 2025
Rodney Lappe, Ph.D.
/s/ John SchmidDirectorMarch 10, 2025
John Schmid
/s/ Arsani William, M.D.DirectorMarch 10, 2025
Arsani William, M.D.
/s/ Heather Berger, Ph.D.DirectorMarch 10, 2025
Heather Berger, Ph.D.
/s/ Deepa PrasadDirectorMarch 10, 2025
Deepa Prasad
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.